Почетна › Дебелина › Флорида › Orlando
Клинички испитувања за Дебелина во Orlando, FL
32 студии за Дебелина бараат учесници на локации во и околу Orlando (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Се регрутираФаза 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Се регрутираФаза 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · на 5 милји
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Се регрутираФаза 3
- West Orange Endocrinology, Ocoee · на 10 милји
The RESET System Pivotal Clinical Trial (Protocol Revision H)
Се регрутира
- Orlando Health, Orlando
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Се регрутираФаза 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Се регрутира
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Се регрутираФаза 1Добредојдени се здрави волонтери
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Се регрутираФаза 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · на 6 милји
- Omega Research Orlando, Altamonte Springs · на 9 милји
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Се регрутираФаза 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Се регрутираФаза 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · на 5 милји
- K2 Medical Research Maitland LLC, Main Office, Maitland · на 6 милји
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Се регрутираФаза 2
- Clinical Neuroscience Solutions, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Се регрутираФаза 3
- Florida Inst For Clin Res LLC, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Се регрутираФаза 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Се регрутираФаза 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Се регрутираФаза 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Се регрутираФаза 3
- Clinical Neuroscience Solution, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Се регрутираФаза 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Се регрутираФаза 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · на 5 милји
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Се регрутираФаза 3
- Conquest Research, Winter Park · на 5 милји
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Се регрутираФаза 2
- Charter Research - Winter Park, Orlando
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Се регрутираФаза 3
- Research Site, Ocoee · на 10 милји
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Се регрутираФаза 3
- AURORA-2 Clinical Site, Winter Park · на 5 милји
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Се регрутираФаза 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · на 5 милји
- и уште 1
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Се регрутираФаза 3
- AURORA-1 Clinical Site, Winter Park · на 5 милји
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Се регрутира
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Се регрутираФаза 3Добредојдени се здрави волонтери
- ACCOMPLISH-2 Research Site, Ocoee · на 10 милји
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Се регрутираФаза 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Се регрутираФаза 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Се регрутираФаза 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Се регрутираФаза 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · на 5 милји
- K2 Medical Research, Maitland · на 6 милји
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Се регрутираФаза 3
- ACCOMPLISH-1 Research Site, Ocoee · на 10 милји
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Се регрутираДобредојдени се здрави волонтери
- AdventHealth Translational Research Institute, Orlando
Испитувања за Дебелина во други градови
- Houston, TX43 студии
- Chicago, IL41 студија
- New York City, NY40 студии
- San Antonio, TX40 студии
- Washington, DC33 студии
- Dallas, TX30 студии
- Boston, MA28 студии
- Las Vegas, NV27 студии
- Miami, FL27 студии
- Baltimore, MD26 студии
- Jacksonville, FL25 студии
- St. Louis, MO25 студии
Други студии во Orlando
- Рак на бели дробови со не-мали клетки44 студии
- Метастатски карцином29 студии
- Прекумерна телесна тежина27 студии
- Алцхајмерова болест25 студии
- Дијабетес тип 225 студии
- Рак (сите типови)24 студии
- Рак на дојка23 студии
- Карцином на јајниците22 студии
- Улцерозен колитис22 студии
- Рак на бели дробови21 студија
- Колоректален карцином19 студии
- Голема депресивна нарушување19 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.